Bezuclastinib + sunitinib combination therapy reached median progression free survival (mPFS) of 19.4-months and 33% ORR in subset of advanced GIST patients with one prior treatment Encouraging long-term safety and
/PRNewswire/ The gastrointestinal stromal tumors therapeutics market is anticipated to grow by USD 1.02 billion, progressing at a CAGR of 6.01% during the.
David (Dave) M. Amlotte, 74, passed away peacefully at home Saturday, March 25, 2023, surrounded by family after a courageous battle with cancer. Dave was bor